Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)
暂无分享,去创建一个
M. Parmar | I. Godsland | N. Clarke | P. Abel | R. Kockelbergh | H. Kynaston | S. Rosen | S. Freeman | R. Langley | F. Cafferty | A. Alhasso | S. Sundaram | R. Jinks | P. Pollock